Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20
Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20
Lake Street以買入評級啓動對絲路醫療的報道，宣佈目標股價爲20美元
Lake Street analyst Frank Takkinen initiates coverage on Silk Road Medical (NASDAQ:SILK) with a Buy rating and announces Price Target of $20.
湖街分析師弗蘭克·塔基寧以買入評級啓動了對絲綢之路醫療（納斯達克股票代碼：SILK）的報道，並宣佈目標股價爲20美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。